Cargando…

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

INTRODUCTION: Systemic sclerosis (SSc) (scleroderma) is a complex autoimmune disease that clinically manifests as progressive fibrosis of the skin and internal organs. Anti-centromere antibodies (ACAs), anti-topoisomerase antibodies (ATAs), and anti-RNA polymerase III antibodies (ARAs) are three mut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gourh, Pravitt, Arnett, Frank C, Assassi, Shervin, Tan, Filemon K, Huang, Mei, Diekman, Laura, Mayes, Maureen D, Reveille, John D, Agarwal, Sandeep K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787259/ https://www.ncbi.nlm.nih.gov/pubmed/19799786 http://dx.doi.org/10.1186/ar2821

Ejemplares similares

Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
por: Gourh, Pravitt, et al.
Publicado: (2010)

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls
por: Arnett, Frank C, et al.
Publicado: (2010)

Osteopontin in Systemic Sclerosis and its Role in Dermal Fibrosis
por: Wu, Minghua, et al.
Publicado: (2012)

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
por: Assassi, Shervin, et al.
Publicado: (2010)

Predictors of Fatigue Severity in Early Systemic Sclerosis: A Prospective Longitudinal Study of the GENISOS Cohort
por: Assassi, Shervin, et al.
Publicado: (2011)

Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study
por: Mihai, Carina, et al.
Publicado: (2020)

Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis
por: Draeger, Hilda T., et al.
Publicado: (2013)

Correction: Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis
por: Draeger, Hilda T., et al.
Publicado: (2014)

Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts
por: Agarwal, Sandeep K, et al.
Publicado: (2011)

Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013)

Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis
por: Brionez, Tamar F, et al.
Publicado: (2009)

Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
por: Farutin, Victor, et al.
Publicado: (2021)

The clinical relevance of autoantibodies in scleroderma
por: Ho, Khanh T, et al.
Publicado: (2003)

The Role of Type 1 Interferon in Systemic Sclerosis
por: Wu, Minghua, et al.
Publicado: (2013)

Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts
por: Zhou, Xiaodong, et al.
Publicado: (2011)

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease
por: Volkmann, Elizabeth R., et al.
Publicado: (2016)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis
por: Jandali, Bochra, et al.
Publicado: (2022)

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need
por: Herrick, Ariane L., et al.
Publicado: (2022)

Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis
por: Hwang, Mark, et al.
Publicado: (2023)

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
por: Guo, Rong-Hong, et al.
Publicado: (2022)

Lack of Association of the CD247 SNP rs2056626 with Systemic Sclerosis in Han Chinese
por: Wang, Jiucun, et al.
Publicado: (2014)

Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations
por: Gorlova, Olga Y., et al.
Publicado: (2018)

Genetic factors in systemic sclerosis
por: Mayes, Maureen D, et al.
Publicado: (2007)

Anti-cytokine autoantibodies in postherpetic neuralgia
por: Bayat, Ahmad, et al.
Publicado: (2015)

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation
por: Ayoglu, Burcu, et al.
Publicado: (2023)

Association of the HLA-DRB1 with Scleroderma in Chinese Population
por: He, Dongyi, et al.
Publicado: (2014)

Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort study
por: Assassi, Shervin, et al.
Publicado: (2022)

HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry
por: Gourh, Pravitt, et al.
Publicado: (2020)

Profiling of HLA-B Alleles for Association Studies with Ankylosing Spondylitis in the Chinese Population
por: Yi, Lin, et al.
Publicado: (2013)

Autoantibodies in the Extraintestinal Manifestations of Celiac Disease
por: Yu, Xuechen B., et al.
Publicado: (2018)

Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database
por: Morgan, Nadia D., et al.
Publicado: (2017)

Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods
por: Xu, Xiao, et al.
Publicado: (2020)

Allergic rhinitis, allergic contact dermatitis and disease comorbidity belong to separate entities with distinct composition of T-cell subsets, cytokines, immunoglobulins and autoantibodies
por: Chai, Wenjia, et al.
Publicado: (2022)

The Effect of Body Fat Distribution on Systemic Sclerosis
por: Villanueva-Martin, Gonzalo, et al.
Publicado: (2022)

Nintedanib in Patients With Systemic Sclerosis–Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score
por: Kuwana, Masataka, et al.
Publicado: (2022)

Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
por: Gorlova, Olga, et al.
Publicado: (2011)

Anti‐C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single‐centre, cross‐sectional study
por: Dijkstra, D.J., et al.
Publicado: (2021)

Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit
por: Kakkar, Vishal, et al.
Publicado: (2022)

Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3vtpf9frfcir1ccren8eh0ok4p